The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 8, 2012, Pages

  Ihara, Yasuo ^a   Morishima Kawashima, Maho ^b   Nixon, Ralph ^c,d  

^a DOSHISHA UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN [1-42]; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; CATHEPSIN D; CHAPERONE; ESCRT PROTEIN; GAMMA SECRETASE; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MONOCLONAL ANTIBODY; PARKIN; POLYCLONAL ANTIBODY; POLYUBIQUITIN; PRESENILIN 1; PRESENILIN 2; PROTEASOME; PROTEIN KINASE; RAB PROTEIN; RAPAMYCIN; TAR DNA BINDING PROTEIN; TAU PROTEIN; UBIQUILIN 1; UBIQUITIN; UBIQUITIN K48; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; AMYLOID; AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ARTICLE; AUTOPHAGY; ENDOCYTOSIS; ENDOSOME; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; LYSOSOME; MASS SPECTROMETRY; MOLECULAR PATHOLOGY; MULTIVESICULAR BODY; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; PAIRED HELICAL FILAMENT; PARKINSON DISEASE; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN QUALITY; SYNAPTIC TRANSMISSION; TAUOPATHY; TRANS GOLGI NETWORK; UBIQUITINATION; ANIMAL; BIOSYNTHESIS; CELL AGING; DISEASE COURSE; DISEASE MODEL; METABOLISM; MOUSE; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; ANIMALS; AUTOPHAGY; CELL AGING; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENDOSOMES; HUMANS; LYSOSOMES; MICE; NERVE DEGENERATION; NEUROFIBRILLARY TANGLES; NEURONS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; TAU PROTEINS; UBIQUITIN;

EID: 84874998766     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a006361     Document Type: Article

References (203)

1. Anderton BH, Breinburg D, Downes MJ, Green PJ, Tomlinson BE, Ulrich J, WoodJN, Kahn J. 1982. Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants. Nature 298: 84-86.
2. Arias E, Cuervo AM. 2011. Chaperone-mediated autophagy in protein quality control. Curr Opin Cell Biol 23: 184-189.
3. Athan ES, Lee JH, Arriaga A, Mayeux RP, Tycko B. 2002. Polymorphisms in the promoter of the human APP gene: Functional evaluation and allele frequencies in Alzheimer disease. Arch Neurol 59: 1793-1799.
4. Babst M, Sato TK, Banta LM, Emr SD. 1997. Endosomal transport function in yeast requires a novel AAA-type ATPase, Vps4p. EMBO J 16: 1820-1831.
5. Bahr BA, Bendiske J. 2002. The neuropathogenic contributions of lysosomal dysfunction. J Neurochem 83: 481-489.
6. Bancher C, Grundke-Iqbal I, Iqbal K, Fried VA, Smith HT, Wisniewski HM. 1991. Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease. Brain Res 539: 11-18.
7. Belin AC, Westerlund M. 2008. Parkinson's disease: A genetic perspective. FEBS J 275: 1377-1383.
8. Belinson H, Lev D, Masliah E, Michaelson DM. 2008. Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficits. J Neurosci 28: 4690-701.
9. Bellettato CM, Scarpa M. 2010. Pathophysiology of neuropathic lysosomal storage disorders. J Inherit Metab Dis 33: 347-362.
10. Bence NF, Sampat RM, Kopito RR. 2001. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292: 1552-1555.
11. Benzing WC, Mufson EJ, Armstrong DM. 1993. Alzheimer's disease-like dystrophic neurites characteristically associated with senile plaques are not found within other neurodegenerative diseases unless amyloid β-protein deposition is present. Brain Res 606: 10-18.
12. Berger Z, Ravikumar B, Menzies FM, Oroz LG, Underwood BR, Pangalos MN, Schmitt I, Wullner U, Evert BO, O'Kane CJ, et al. 2006. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum Mol Genet 15: 433-442.
13. Berke SJ, Paulson HL. 2003. Protein aggregation and the ubiquitin proteasome pathway: Gaining the UPPer hand on neurodegeneration. Curr Opin Genet Dev 13: 253-261.
14. Bertram L, Hiltunen M, Parkinson M, Ingelsson M, Lange C, Ramasamy K, Mullin K, Menon R, Sampson AJ, Hsiao MY, et al. 2005. Family-based association between Alzheimer's disease and variants in UBQLN1. New Engl J Med 352: 884-894.
15. Bingol B, Sheng M. 2011. Deconstruction for reconstruction: The role of proteolysis in neural plasticity and disease. Neuron 69: 22-32.
16. Boland B, Nixon RA. 2006. Neuronal macroautophagy: From development to degeneration. Mol Aspects Med 27: 503-519.
17. Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA. 2008. Autophagy induction and autophagosome clearance in neurons: Relationship to autophagic pathology in Alzheimer's disease. J Neurosci 28: 6926-6937.
18. Brion JP, Couck AM, Passareiro E, Flament-Durand J. 1985. Neurofibrillary tangles of Alzheimer's disease: An immunohistochemical study. J Submicrosc Cytol 17: 89-96.
19. Brown MR, Bondada V, Keller JN, Thorpe J, Geddes JW. 2005a. Proteasome or calpain inhibition does not alter cellular tau levels in neuroblastoma cells or primary neurons. J Alzheimer's Dis 7: 15-24.
20. Brown TC, Tran IC, Backos DS, Esteban JA. 2005b. NMDA receptor-dependent activation of the small GTPase Rab5 drives the removal of synaptic AMPA receptors during hippocampal LTD. Neuron 45: 81-94.
21. Butler D, Hwang J, Estick C, Nishiyama A, Kumar SS, Baveghems C, Young-Oxendine HB, Wisniewski ML, Charalambides A, Bahr BA. 2011. Protective effects of positive lysosomal modulation in Alzheimer's disease transgenic mouse models. PLoS One 6: e20501.
22. Caccamo A, Majumder S, Richardson A, Strong R, Oddo S. 2010. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-β, and Tau: Effects on cognitive impairments. J Biol Chem 285: 13107-13120.
23. Cai Q, Lu L, Tian JH, Zhu YB, Qiao H, Sheng ZH. 2010. Snapin-regulated late endosomal transport is critical for efficient autophagy-lysosomal function in neurons. Neuron 68: 73-86.
24. Cardozo C, Michaud C. 2002. Proteasome-mediated degradation of tau proteins occurs independently of the chymotrypsin-like activity by a nonprocessive pathway. Arch Biochem Biophys 408: 103-110.
25. Cataldo AM, Nixon RA. 1990. Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. Proc Natl Acad Sci 87: 3861-3865.
26. Cataldo AM, Paskevich PA, Kominami E, Nixon RA. 1991. Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. Proc Natl Acad Sci 88: 10998-11002.
27. Cataldo AM, Barnett JL, Pieroni C, Nixon RA. 1997. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: Neuropathologic evidence for a mechanism of increased β-amyloidogenesis. J Neurosci 17: 6142-6151.
28. Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT, Nixon RA. 2000. Endocytic pathway abnormalities precede amyloid β deposition in sporadic Alzheimer's disease and Down syndrome: Differential effects of APOE genotype and presenilin mutations. Am J Pathol 157: 277-286.
29. Cataldo AM, Peterhoff CM, Schmidt SD, Terio NB, Duff K, Beard M, MathewsPM, Nixon RA. 2004. Presenilin mutations in familial Alzheimer disease and transgenic mouse models accelerate neuronal lysosomal pathology. J Neuropathol Exp Neurol 63: 821-830.
30. Cataldo AM, Mathews PM, Boiteau AB, Hassinger LC, Peterhoff CM, Jiang Y, Mullaney K, Neve RL, Gruenberg J, Nixon RA. 2008. Down syndrome fibroblast model of Alzheimer-related endosome pathology. Accelerated endocytosis promotes late endocytic defects. Am J Pathol 173: 370-384.
31. Chen B, Borinstein SC, Gillis J, Sykes VW, Bogler O. 2000. The glioma-associated protein SETA interacts with AIP1/Alix and ALG-2 and modulates apoptosis in astrocytes. J Biol Chem 275: 19275-19281.
32. Chen X, Wagener JF, Morgan DH, Hui L, Ghribi O, Geiger JD. 2010. Endolysosome mechanisms associated with Alzheimer's disease-like pathology in rabbits ingesting cholesterol-enriched diet. J Alzheimer's Dis 22: 1289-1303.
33. Cherra SJ 3rd., Dagda RK, Chu CT. 2010. Review: Autophagy and neurodegeneration: Survival at a cost? Neuropathol Appl Neurobiol 36: 125-132.
34. Choi J, Levey AI, Weintraub ST, Rees HD, Gearing M, Chin LS, Li L. 2004. Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J Biol Chem 279: 13256-13264.
35. Ciechanover A, Finley D, Varshavsky A. 1984. Ubiquitin dependence of selective protein degradation demonstrated in the mammalian cell cycle mutant ts85. Cell 37: 57-66.
36. Cirrito JR, Kang J-E, Lee J, Stewart FR, Verges DK, Silverio LM, Bu G, MennerickS, Holtzman DM. 2008. Endocytosis is required for synaptic activity-dependent release of amyloid-β in vivo. Neuron 58: 42-51.
37. Cooper JD, Salehi A, Delcroix JD, Howe CL, Belichenko PV, Chua-Couzens J, Kilbridge JF, Carlson EJ, Epstein CJ, Mobley WC. 2001. Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proc Natl Acad Sci 98: 10439-10444.
38. Cossec JC, Simon A, Marquer C, Moldrich RX, Leterrier C, Rossier J, DuyckaertsC, Lenkei Z, Potier MC. 2010. Clathrin-dependent APP endocytosis and Aβ secretion are highly sensitive to the level of plasma membrane cholesterol. Biochim Biophys Acta 1801: 846-852.
39. Cripps D, Thomas SN, Jeng Y, Yang F, Davies P, Yang AJ. 2006. Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-Tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6 ubiquitin conjugation. J Biol Chem 281: 10825-10838.
40. Cuervo AM. 2004. Autophagy: Many paths to the same end. Mol Cell Biochem 263: 55-72.
41. Cuervo AM, Palmer A, Rivett AJ, Knecht E. 1995. Degradation of proteasomes by lysosomes in rat liver. Eur J Biochem 227: 792-800.
42. David DC, Layfield R, Serpell L, Narain Y, Goedert M, Spillantini MG. 2002. Proteasomal degradation of tau protein. J Neurochem 83: 176-185.
43. Delcroix JD, Valletta JS, Wu C, Hunt SJ, Kowal AS, Mobley WC. 2003. NGF signaling in sensory neurons: Evidence that early endosomes carry NGF retrograde signals. Neuron 39: 69-84.
44. Delcroix JD, Valletta J, Wu C, Howe CL, Lai CF, Cooper JD, Belichenko PV, Salehi A, Mobley WC. 2004. Trafficking the NGF signal: Implications for normal and degenerating neurons. Prog Brain Res 146: 3-23.
45. Dhaka A, Costa RM, Hu H, Irvin DK, Patel A, Kornblum HI, Silva AJ, O'Dell TJ, Colicelli J. 2003. The RAS effector RIN1 modulates the formation of aversive memories. J Neurosci 23: 748-757.
46. Dickey CA, Yue M, Lin WL, Dickson DW, Dunmore JH, Lee WC, Zehr C, West G, Cao S, Clark AM, et al. 2006. Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho-and caspase-3-cleaved tau species. J Neurosci 26: 6985-6996.
47. Dikic I, Johansen T, Kirkin V. 2010. Selective autophagy in cancer development and therapy. Cancer Res 70: 3431-3434.
48. Dolan PJ, Johnson GV. 2010. A caspase cleaved form of tau is preferentially degraded through the autophagy pathway. J Biol Chem 285: 21978-21987.
49. Eckman EA, Eckman CB. 2005. Aβ-degrading enzymes: Modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention. Biochem Soc Trans 33: 1101-1105.
50. Finley D, Ciechanover A, Varshavsky A. 1984. Thermolability of ubiquitin-activating enzyme from the mammalian cell cycle mutant ts85. Cell 37: 43-55.
51. Fischer DF, De Vos RA, Van Dijk R, De Vrij FM, Proper EA, Sonnemans MA, Verhage MC, Sluijs JA, Hobo B, Zouambia M, et al. 2003. Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain. FASEB J 17: 2014-2024.
52. Fischer DF, van Dijk R, van Tijn P, Hobo B, Verhage MC, van der Schors RC, LiKW, van Minnen J, Hol EM, van Leeuwen FW. 2009. Long-term proteasome dysfunction in the mouse brain by expression of aberrant ubiquitin. Neurobiol Aging 30: 847-863.
53. Florez-McClure ML, Hohsfield LA, Fonte G, Bealor MT, Link CD. 2007. Decreased insulin-receptor signaling promotes the autophagic degradation of β-amyloid peptide in C. elegans. Autophagy 3: 569-580.
54. Fortun J, Dunn WA Jr., Joy S, Li J, Notterpek L. 2003. Emerging role for autophagy in the removal of aggresomes in Schwann cells. J Neurosci 23: 10672-10680.
55. Frautschy SA, Yang F, Calderon L, Cole GM. 1996. Rodent models of Alzheimer's disease: Rat A β infusion approaches to amyloid deposits. Neurobiol Aging 17: 311-321.
56. Frautschy SA, Horn DL, Sigel JJ, Harris-White ME, Mendoza JJ, Yang F, Saido TC, Cole GM. 1998. Protease inhibitor coinfusion with amyloid β-protein results in enhanced deposition and toxicity in rat brain. J Neurosci 18: 8311-8321.
57. Gallastegui N, Groll M. 2010. The 26S proteasome: Assembly and function of a destructive machine. Trends Biochem Sci 35: 634-642.
58. Garcia-Arencibia M, Hochfeld WE, Toh PP, Rubinsztein DC. 2010. Autophagy, a guardian against neurodegeneration. Semin Cell Dev Biol 21: 691-698.
59. Ginsberg SD, Alldred MJ, Counts SE, Cataldo AM, Neve RL, Jiang Y, Wuu J, ChaoMV, Mufson EJ, Nixon RA, et al. 2010. Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression. Biol Psychiat 68: 885-893.
60. Glabe C. 2001. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease. J Mol Neurosci 17: 137-145.
61. Goldberg AL. 2003. Protein degradation and protection against misfolded or damaged proteins. Nature 426: 895-899.
62. Gómez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT. 1997. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 41: 17-24.
63. Gonatas NK. 1967. Neocortical synapses in a presenile dementia. J Neuropathol Exp Neurol 26: 150-151.
64. Gong B, Cao Z, Zheng P, Vitolo OV, Liu S, Staniszewski A, Moolman D, ZhangH, Shelanski M, Arancio O. 2006. Ubiquitin hydrolase Uch-L1 rescues β-amyloid-induced decreases in synaptic function and contextual memory. Cell 126: 775-788.
65. Gordon PB, Seglen PO. 1988. Prelysosomal convergence of autophagic and endocytic pathways. Biochem Biophys Res Commun 151: 40-47.
66. Gout I, Middleton G, Adu J, Ninkina NN, Drobot LB, Filonenko V, Matsuka G, Davies AM, Waterfield M, Buchman VL. 2000. Negative regulation of PI 3-kinase by Ruk, a novel adaptor protein. EMBO J 19: 4015-4025.
67. Grbovic OM, Mathews PM, Jiang Y, Schmidt SD, Dinakar R, Summers-Terio NB, Ceresa BP, Nixon RA, Cataldo AM. 2003. Rab5-stimulated up-regulation of the endocytic pathway increases intracellular β-cleaved amyloid precursor protein carboxyl-terminal fragment levels and Aβ production. J Biol Chem 278: 31261-31268.
68. Greer PL, Hanayama R, Bloodgood BL, Mardinly AR, Lipton DM, Flavell SW, KimTK, Griffith EC, Waldon Z, Maehr R, et al. 2010. The Angelman syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell 140: 704-716.
69. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM. 1986. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 261: 6084-6089.
70. Grune T, Shringarpure R, Sitte N, Davies K. 2001. Age-related changes in protein oxidation and proteolysis in mammalian cells. J Gerontol A Biol Sci Med Sci 56: B459-B467.
71. Guenette SY. 2003. Mechanisms of Aβ clearance and catabolism. Neuromol Med 4: 147-160.
72. Haapasalo A, Viswanathan J, Bertram L, Soininen H, Tanzi RE, Hiltunen M. 2010. Emerging role of Alzheimer's disease-associated ubiquilin-1 in protein aggregation. Biochem Soc Trans 38: 150-155.
73. Haas AL, Bright PM. 1985. The immunochemical detection and quantitation of intracellular ubiquitin-protein conjugates. J Biol Chem 260: 12464-12473.
74. Hamano T, Gendron TF, Causevic E, Yen SH, Lin WL, Isidoro C, Deture M, KoLW. 2008. Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression. Eur J Neurosci 27: 1119-30.
75. Hasegawa M, Morishima-Kawashima M, Takio K, Suzuki M, Titani K, Ihara Y. 1992. Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain. J Biol Chem 267: 17047-17054.
76. Hasegawa M, Fujiwara H, Nonaka T, Wakabayashi K, Takahashi H, Lee VM, Trojanowski JQ, Mann D, Iwatsubo T. 2002. Phosphorylated α-synuclein is ubiquitinated in α-synucleinopathy lesions. J Biol Chem 277: 49071-49076.
77. Hegde AN, Goldberg AL, Schwartz JH. 1993. Regulatory subunits of cAMP-dependent protein kinases are degraded after conjugation to ubiquitin: A molecular mechanism underlying long-term synaptic plasticity. Proc Natl Acad Sci 90: 7436-7440.
78. Hegde AN, Inokuchi K, Pei W, Casadio A, Ghirardi M, Chain DG, Martin KC, Kandel ER, Schwartz JH. 1997. Ubiquitin C-terminal hydrolase is an immediate-early gene essential for long-term facilitation in Aplysia. Cell 89: 115-126.
79. Heinrich M, Wickel M, Schneider-Brachert W, Sandberg C, Gahr J, SchwandnerR, Weber T, Saftig P, Peters C, Brunner J, et al. 1999. Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J 18: 5252-5263.
80. Hollingworth P, Harold D, Jones L, Owen MJ, Williams J. 2011. Alzheimer's disease genetics: Current knowledge and future challenges. Int J Geriatr Psychiat 26: 793-802.
81. Hsia AY, Masliah E, McConlogue L, Yu GQ, Tatsuno G, Hu K, Kholodenko D, Malenka RC, Nicoll RA, Mucke L. 1999. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci 96: 3228-3233.
82. Hu X, Pickering E, Liu YC, Hall S, Fournier H, Katz E, Dechairo B, John S, Van Eerdewegh P, Soares H. 2011. Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease. PLoS One 6: e16616.
83. Hurley JH. 2010. The ESCRT complexes. Crit Rev Biochem Mol Biol 45: 463-487.
84. Ihara Y, Abraham C, Selkoe DJ. 1983. Antibodies to paired helical filaments in Alzheimer's disease do not recognize normal brain proteins. Nature 304: 727-729.
85. Ivy GO, Schottler F, Wenzel J, Baudry M, Lynch G. 1984. Inhibitors of lysosomal enzymes: Accumulation of lipofuscin-like dense bodies in the brain. Science 226: 985-987.
86. Iwatsubo T, Hasegawa M, Esaki Y, Ihara Y. 1992. Lack of ubiquitin immunoreactivities at both ends of neuropil threads-Possible bidirectional growth of neuropil threads. Am J Pathol 140: 277-282.
87. Ji ZS, Miranda RD, Newhouse YM, Weisgraber KH, Huang Y, Mahley RW. 2002. Apolipoprotein E4 potentiates amyloid β peptide-induced lysosomal leakage and apoptosis in neuronal cells. J Biol Chem 277: 21821-21828.
88. Ji ZS, Mullendorff K, Cheng IH, Miranda RD, Huang Y, Mahley RW. 2006. Reactivity of apolipoprotein E4 and amyloid β peptide: Lysosomal stability and neurodegeneration. J Biol Chem 281: 2683-2692.
89. Jiang Y, Mullaney KA, Peterhoff CM, Che S, Schmidt SD, Boyer-Boiteau A, Ginsberg SD, Cataldo AM, Mathews PM, Nixon RA. 2010. Alzheimer's-related endosome dysfunction in Down syndrome is Aβ-independent but requires APP and is reversed by BACE-1 inhibition. Proc Natl Acad Sci 107: 1630-1635.
90. Jin M, Shepardson N, Yang T, Chen G, Walsh D, Selkoe DJ. 2011. Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc Natl Acad Sci 108: 5819-5824.
91. Keck S, Nitsch R, Grune T, Ullrich O. 2003. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease. J Neurochem 85: 115-122.
92. Keller JN, Hanni KB, Markesbery WR. 2000. Impaired proteasome function in Alzheimer's disease. J Neurochem 75: 436-439.
93. Keller JN, Gee J, Ding Q. 2002. The proteasome in brain aging. Ageing Res Rev 1: 279-293.
94. Kelly BT, Owen DJ. 2011. Endocytic sorting of transmembrane protein cargo. Curr Opin Cell Biol 23: 404-412.
95. Kessels HW, Malinow R. 2009. Synaptic AMPA receptor plasticity and behavior. Neuron 61: 340-350.
96. Khurana V, Elson-Schwab I, Fulga TA, Sharp KA, Loewen CA, Mulkearns E, Tyynela J, Scherzer CR, Feany MB. 2010. Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo. PLoS Genet 6: e1001026.
97. Koike M, Shibata M, Waguri S, Yoshimura K, Tanida I, Kominami E, Gotow T, Peters C, von Figura K, Mizushima N, et al. 2005. Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease). Am J Pathol 167: 1713-1728.
98. Kondo J, Honda T, Mori H, Hamada Y, Miura R, Ogawara M, Ihara Y. 1988. The carboxyl third of tau is tightly bound to paired helical filaments. Neuron 1: 827-834.
99. Korolchuk VI, Mansilla A, Menzies FM, Rubinsztein DC. 2009a. Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates. Mol Cell 33: 517-527.
100. Korolchuk VI, Menzies FM, Rubinsztein DC. 2009b. A novel link between autophagy and the ubiquitin-proteasome system. Autophagy 5: 862-863.
101. Kosaka K. 1978. Lewy bodies in cerebral cortex, report of three cases. Acta Neuropathol 42: 127-134.
102. Kosik KS, Joachim CL, Selkoe DJ. 1986. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical fragments in Alzheimer disease. Proc Natl Acad Sci 83: 4044-4048.
103. Kroemer G, Jaattela M. 2005. Lysosomes and autophagy in cell death control. Nat Rev Cancer 5: 886-97.
104. Kuzuhara S, Mori H, Izumiyama N, Yoshimura M, Ihara Y. 1988. Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study. Acta Neuropathol 75: 345-353.
105. Laifenfeld D, Patzek LJ, McPhie DL, Chen Y, Levites Y, Cataldo AM, Neve RL. 2007. Rab5 mediates an amyloid precursor protein signaling pathway that leads to apoptosis. J Neurosci 27: 7141-7153.
106. Lam YA, Pickart CM, Alban A, Landon M, Jamieson C, Ramage R, Mayer RJ, Layfield R. 2000. Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc Natl Acad Sci 97: 9902-9906.
107. Larsen KE, Sulzer D. 2002. Autophagy in neurons: A review. Histol Histopathol 17: 897-908.
108. LeBlanc AC, Goodyer CG. 1999. Role of endoplasmic reticulum, endosomal-lysosomal compartments, and microtubules in amyloid precursor protein metabolism of human neurons. J Neurochem 72: 1832-42.
109. Lee JH, Yu WH, Kumar A, Lee S, Mohan PS, Peterhoff CM, Marinez-Vicente M, Massey AG, Sovak G, Uchiyama Y, et al. 2010. Presenilin 1 (PS1) is required for v-ATPase targeting and autolysosome acidification: PS1 mutations in Alzheimer's disease disrupt lysosomal proteolysis and autophagy. Cell 141: 1146-1158.
110. Lee S, Sato Y, Nixon RA. 2011a. Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer's-like axonal dystrophy. J Neurosci 31: 7817-7830.
111. Lee S, Saito Y, Nixon RA. 2011b. Primary lysosomal dysfunction causes cargo-specific deficits of axonal transport leading to Alzheimer's-like neuritic dystrophy. Autophagy 7: in press.
112. A receptors to the plasma membrane in neurons. J Neurosci 24: 11429-11438.
113. Levine B, Klionsky DJ. 2004. Development by self-digestion; molecular mechanisms and biological functions of autophagy. Dev Cell 6: 463-477.
114. Levine B, Mizushima N, Virgin HW. 2011. Autophagy in immunity and inflammation. Nature 469: 323-335.
115. Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D. 2009. Soluble oligomers of amyloid β protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62: 788-801.
116. Lim JP, Gleeson PA. 2011. Macropinocytosis: An endocytic pathway for internalising large gulps. Immunol Cell Biol doi: 10. 1038/icb. 2011. 20.
117. Ling D, Song HJ, Garza D, Neufeld TP, Salvaterra PM. 2009. Aβ42-induced neurodegeneration via an age-dependent autophagic-lysosomal injury inDrosophila. PLoS One 4: e4201.
118. Lipinski MM, Zheng B, Lu T, Yan Z, Py BF, Ng A, Xavier RJ, Li C, Yankner BA, Scherzer CR, et al. 2010. Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease. Proc Natl Acad Sci 107: 14164-14169.
119. Lopez-Salon M, Alonso M, Vianna MR, Viola H, Mello e Souza T, Izquierdo I, Pasquini JM, Medina JH. 2001. The ubiquitin-proteasome cascade is required for mammalian long-term memory formation. Eur J Neurosci 4: 1820-1826.
120. Lowe J, Blanchard A, Morrell K, Lennox G, Reynolds L, Billett M, Landon M, Mayer RJ. 1988. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease. J Pathol 155: 9-15.
121. Mandelkow E-M, Mandelkow E. 2011. Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006247.
122. Margallo-Lana M, Morris CM, Gibson AM, Tan AL, Kay DW, Tyrer SP, Moore BP, Ballard CG. 2004. Influence of the amyloid precursor protein locus on dementia in Down syndrome. Neurology 62: 1996-1998.
123. Masliah E, Mallory M, Deerinck T, DeTeresa R, Lamont S, Miller A, Terry RD, Carragher B, Ellisman M. 1993. Re-evaluation of the structural organization of the neuritic plaques in Alzheimer's disease. J Neuropathol Exp Neurol 52: 619-632.
124. Mathews PM, Guerra CB, Jiang Y, Grbovic OM, Kao BH, Schmidt SD, Dinakar R, Mercken M, Hille-Rehfeld A, Rohrer J, et al. 2002. Alzheimer's disease-related overexpression of the cation-dependent mannose 6-phosphate receptor increases Aβ secretion: Role for altered lysosomal hydrolase distribution in β-amyloidogenesis. J Biol Chem 277: 5299-5307.
125. McCray BA, Taylor JP. 2008. The role of autophagy in age-related neurodegeneration. Neurosignals 16: 75-84.
126. Missotten M, Nichols A, Rieger K, Sadoul R. 1999. Alix, a novel mouse protein undergoing calcium-dependent interaction with the apoptosis-linked-gene 2 (ALG-2) protein. Cell Death Differ 6: 124-129.
127. Mori H, Kondo J, Ihara Y. 1987. Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 235: 1641-1644.
128. Morimoto T, Ide T, Ihara Y, Tamura A, Kirino T. 1996. Transient ischemia depletes free ubiquitin in the gerbil hippocampal CA1 neurons. Am J Pathol 148: 249-257.
129. Morishima-Kawashima M, Hasegawa M, Takio K, Suzuki M, Titani K, Ihara Y. 1993. Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments. Neuron 10: 1151-1160.
130. Mueller-Steiner S, Zhou Y, Arai H, Roberson ED, Sun B, Chen J, Wang X, Yu G, Esposito L, Mucke L, et al. 2006. Antiamyloidogenic and neuroprotective functions of cathepsin B: Implications for Alzheimer's disease. Neuron 51: 703-714.
131. Mullins C, Bonifacino JS. 2001. The molecular machinery for lysosome biogenesis. Bioessays 23: 333-343.
132. Murayama S, Mori H, Ihara Y, Bouldin TW, Suzuki K, Tomonaga M. 1990a. Immunocytochemical and ultrastructural studies of lower motor neurons in amyotrophic lateral sclerosis. Ann Neurol 27: 137-148.
133. Murayama S, Mori H, Ihara Y, Tomonaga M. 1990b. Immunocytochemical and ultrastructural studies of Pick's disease. Ann Neurol 27: 394-405.
134. Narendra D, Tanaka A, Suen DF, Youle RJ. 2009. Parkin-induced mitophagy in the pathogenesis of Parkinson disease. Autophagy 5: 706-708.
135. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, BruceJ, Schuck T, Grossman M, Clark CM, et al. 2006. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130-133.
136. +)-ATPases-nature's most versatile proton pumps. Nat Rev Mol Cell Biol 3: 94-103.
137. Nixon RA. 2004. Niemann-Pick Type C disease and Alzheimer's disease: The APP-endosome connection fattens up. Am J Pathol 164: 757-761.
138. Nixon RA. 2007. Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci 120: 4081-4091.
139. Nixon RA, Cataldo AM. 2006. Lysosomal system pathways: Genes to neurodegeneration in Alzheimer's disease. J Alzheimer's Dis 9: 277-289.
140. Nixon RA, Yang DS. 2011. Autophagy failure in Alzheimer's disease-Locating the primary defect. Neurobiol Dis 43: 38-45.
141. Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, Cataldo A, Cuervo AM. 2005. Extensive involvement of autophagy in Alzheimer disease: An immuno-electron microscopy study. J Neuropathol Exp Neurol 64: 113-122.
142. Nixon RA, Yang DS, Lee JH. 2008. Neurodegenerative lysosomal disorders: A continuum from development to late age. Autophagy 4: 590-599.
143. Nukina N, Ihara Y. 1986. One of the antigenic determinants of paired helical filaments is related to tau protein. J Biochem 99: 1541-1544.
144. Nukina N, Kosik KS, Selkoe DJ. 1987. Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein. Proc Natl Acad Sci 84: 3415-3419.
145. Ohmi K, Kudo LC, Ryazantsev S, Zhao HZ, Karsten SL, Neufeld EF. 2009. Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathy. Proc Natl Acad Sci 106: 8332-8337.
146. Ohsumi Y. 2001. Molecular dissection of autophagy: Two ubiquitin-like systems. Nat Rev Mol Cell Biol 2: 211-216.
147. Overly CC, Hollenbeck PJ. 1996. Dynamic organization of endocytic pathways in axons of cultured sympathetic neurons. J Neurosci 16: 6056-6064.
148. Paine S, Bedford L, Thorpe JR, Mayer RJ, Cavey JR, Bajaj N, Sheppard PW, Lowe J, Layfield R. 2009. Immunoreactivity to Lys63-linked polyubiquitin is a feature of neurodegeneration. Neurosci Lett 460: 205-208.
149. 1-28 peptide. J Mol Biol 379: 589-596.
150. Petrucelli L, Dickson D, Kehoe K, Taylor J, Snyder H, Grover A, De Lucia M, McGowan E, Lewis J, Prihar G, et al. 2004. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum Mol Genet 13: 703-714.
151. Pickford F, Masliah E, Britschgi M, Lucin K, Narasimhan R, Jaeger PA, Small S, Spencer B, Rockenstein E, Levine B, et al. 2008. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid β accumulation in mice. J Clin Invest 118: 2190-2199.
152. Pike JW, Donaldson CA, Marion SL, Haussler MR. 1982. Development of hybridomas secreting monoclonal antibodies to the chicken intestinal 1 α, 25-dihydroxyvitamin D3 receptor. Proc Natl Acad Sci 79: 7719-7723.
153. Pillay CS, Elliott E, Dennison C. 2002. Endolysosomal proteolysis and its regulation. Biochem J 363: 417-429.
154. Piper RC, Luzio JP. 2001. Late endosomes: Sorting and partitioning in multivesicular bodies. Traffic 2: 612-621.
155. Poteryaev D, Datta S, Ackema K, Zerial M, Spang A. 2010. Identification of the switch in early-to-late endosome transition. Cell 141: 497-508.
156. Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere A, Vital A, Dumanchin C, Feuillette S, Brice A, Vercelletto M, et al. 2006. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38: 24-26.
157. Rowland AM, Richmond JE, Olsen JG, Hall DH, Bamber BA. 2006. Presynaptic terminals independently regulate synaptic clustering and autophagy of GABAA receptors in Caenorhabditis elegans. J Neurosci 26: 1711-1720.
158. Roy AK, Oh T, Rivera O, Mubiru J, Song CS, Chatterjee B. 2002. Impacts of transcriptional regulation on aging and senescence. Ageing Res Rev 1: 367-380.
159. Rusten TE, Simonsen A. 2008. ESCRT functions in autophagy and associated disease. Cell Cycle 7: 1166-1172.
160. Ryazantsev S, Yu WH, Zhao HZ, Neufeld EF, Ohmi K. 2007. Lysosomal accumulation of SCMAS (subunit c of mitochondrial ATP synthase) in neurons of the mouse model of mucopolysaccharidosis III B. Mol Genet Metab 90: 393-401.
161. Sahu R, Kaushik S, Clement CC, Cannizzo ES, Scharf B, Follenzi A, Potolicchio I, Nieves E, Cuervo AM, Santambrogio L. 2011. Microautophagy of cytosolic proteins by late endosomes. Dev Cell 20: 131-139.
162. Saido T, Leissring MA. 2011. Proteolytic degradation of amyloid β-protein. Cold Spring Harb Perspect doi: 10. 1101. cshperspect. a006379.
163. Schmidt ML, DiDario AG, Lee VM, Trojanowski JQ. 1994. An extensive network of PHF tau-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease. FEBS Lett 344: 69-73.
164. Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, BisJC, Smith AV, Carassquillo MM, Lambert JC, et al. 2010. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303: 1832-1840.
165. Setsuie R, Wada K. 2007. The functions of UCH-L1 and its relation to neurodegenerative diseases. Neurochem Int 51: 105-111.
166. Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, ErdinSU, Huynh T, Medina D, Colella P, et al. 2011. TFEB links autophagy to lysosomal biogenesis. Science 332: 1429-1433.
167. Simonsen A, Tooze SA. 2009. Coordination of membrane events during autophagy by multiple class III PI3-kinase complexes. J Cell Biol 186: 773-782.
168. Sleegers K, Brouwers N, Gijselinck I, Theuns J, Goossens D, Wauters J, Del-Favero J, Cruts M, van Duijn CM, Van Broeckhoven C. 2006. APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. Brain 129: 2977-2983.
169. Smemo S, Nowotny P, Hinrichs AL, Kauwe JS, Cherny S, Erickson K, Myers AJ, Kaleem M, Marlowe L, Gibson AM, et al. 2006. Ubiquilin 1 polymorphisms are not associated with late-onset Alzheimer's disease. Ann Neurol 59: 21-26.
170. Sohal RS, Mockett RJ, Orr WC. 2002. Mechanisms of aging: An appraisal of the oxidative stress hypothesis. Free Radic Biol Med 33: 575-586.
171. Soto C. 2003. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci 4: 49-60.
172. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. 1997. Alpha-synuclein in Lewy bodies. Nature 388: 839-840.
173. Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, Bredesen D, Richardson A, Strong R, Galvan V. 2010. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-β levels in a mouse model of Alzheimer's disease. PLoS One 5: e9979.
174. Sun B, Zhou Y, Halabisky B, Lo I, Cho SH, Mueller-Steiner S, Devidze N, WangX, Grubb A, Gan L. 2008. Cystatin C-cathepsin B axis regulates amyloid β levels and associated neuronal deficits in an animal model of Alzheimer's disease. Neuron 60: 247-257.
175. Syntichaki P, Tavernarakis N. 2003. The biochemistry of neuronal necrosis: Rogue biology? Nat Rev Neurosci 4: 672-684.
176. Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, Yamaguchi H, Beal MF, Xu H, Greengard P, Gouras GK. 2002. Intraneuronal Alzheimer aβ42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 161: 1869-1879.
177. Tank EM, True HL. 2009. Disease-associated mutant ubiquitin causes proteasomal impairment and enhances the toxicity of protein aggregates. PLoS Genet 5: e1000382.
178. Terman A. 2001. Garbage catastrophe theory of aging: Imperfect removal of oxidative damage? Redox Rep 6: 15-26.
179. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R. 1991. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 30: 572-580.
180. Tian Y, Bustos V, Flajolet M, Greengard P. 2011. A small-molecule enhancer of autophagy decreases levels of A{β} and APP-CTF via Atg5-dependent autophagy pathway. FASEB J 25: 1934-1942.
181. Tresse E, Salomons FA, Vesa J, Bott LC, Kimonis V, Yao TP, Dantuma NP, TaylorJP. 2010. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy 6: 217-227.
182. Troen BR. 2003. The biology of aging. Mt Sinai J Med 70: 3-22.
183. Tseng BP, Green KN, Chan JL, Blurton-Jones M, LaFerla FM. 2008. Aβ inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol Aging 29: 1607-1618.
184. van Leeuwen FW, de Kleijn DP, van den Hurk HH, Neubauer A, Sonnemans MA, et al. 1998. Frameshift mutants of β amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 279: 242-247.
185. 2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 271: 521-525.
186. 2+-dependent reaction. J Biol Chem 274: 1533-1540.
187. Walsh DM, Selkoe DJ. 2004. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44: 181-189.
188. Wang Y, Martinez-Vicente M, Kruger U, Kaushik S, Wong E, Mandelkow EM, Cuervo AM, Mandelkow E. 2009. Tau fragmentation, aggregation and clearance: The dual role of lysosomal processing. Hum Mol Genet 18: 4153-4170.
189. Weidberg H, Shvets E, Elazar Z. 2011. Biogenesis and cargo selectivity of autophagosomes. Annu Rev Biochem 80: 125-156.
190. Wischik CM, Crowther RA, Stewart M, Roth M. 1985. Subunit structure of paired helical filaments in Alzheimer's disease. J Cell Biol 100: 1905-1912.
191. Wong E, Cuervo AM. 2010. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci 13: 805-811.
192. Wood JG, Mirra SS, Pollock NJ, Binder LI. 1986. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau). Proc Natl Acad Sci 83: 4040-4043.
193. Xu P, Peng J. 2006. Dissecting the ubiquitin pathway by mass spectometry. Biochim Biophys Acta 1764: 1940-1947.
194. Xu P, Peng J. 2008. Characterization of polyubiquitin chain structure by middle-down mass spectrometry. Anal Chem 80: 3438-3444.
195. Yang AJ, Chandswangbhuvana D, Margol L, Glabe CG. 1998. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Aβ1-42 pathogenesis. J Neurosci Res 52: 691-698.
196. Yang DS, Kumar A, Stavrides P, Peterson J, Peterhoff CM, Pawlik M, Levy E, Cataldo AM, Nixon RA. 2008. Neuronal apoptosis and autophagy cross talk in aging PS/APP mice, a model of Alzheimer's disease. Am J Pathol 173: 665-681.
197. Yang DS, Stavrides P, Mohan PS, Kaushik S, Kumar A, Ohno M, Schmidt SD, Wesson D, Bandyopadhyay U, Jiang Y, et al. 2011. Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits. Brain 134: 258-277.
198. Yoshii SR, Kishi C, Ishihara N, Mizushima N. 2011. Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane. J Biol Chem 286: 19630-19640.
199. Youle RJ, Narendra DP. 2011. Mechanisms of mitophagy. Nat Rev Mol Cell Biol 12: 9-14.
200. Yu WH, Cuervo AM, Kumar A, Peterhoff CM, Schmidt SD, Lee J-H, Mohan PS, Mercken M, Farmery MR, Tjernberg LO, et al. 2005. Macroautophagy-A novel β-amyloid peptide-generating pathway activated in Alzheimer's disease. J Cell Biol 171: 87-98.
201. Zhang M. 2008. Endocytic mechanisms and drug discovery in neurodegenerative diseases. Front Biosci 13: 6086-6105.
202. 2+-dependent proteasome protease system. J Neural Transm 112: 547-555.
203. Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, Lecker SH, GoldbergAL. 2007. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 6: 472-483.